ADDEX PHARMACEUTICALS SA has a total of 260 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are TARGASEPT INK, STANGELAND ERIC L and XENON PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 90 | |
#2 | WIPO (World Intellectual Property Organization) | 27 | |
#3 | Canada | 21 | |
#4 | Australia | 20 | |
#5 | EPO (European Patent Office) | 18 | |
#6 | Brazil | 15 | |
#7 | China | 13 | |
#8 | Republic of Korea | 9 | |
#9 | Ukraine | 8 | |
#10 | United States | 7 | |
#11 | EAPO (Eurasian Patent Organization) | 6 | |
#12 | Mexico | 5 | |
#13 | Hong Kong | 3 | |
#14 | Hungary | 3 | |
#15 | Chile | 2 | |
#16 | Israel | 2 | |
#17 | South Africa | 2 | |
#18 | Czechia | 1 | |
#19 | Jordan | 1 | |
#20 | Norway | 1 | |
#21 | New Zealand | 1 | |
#22 | Philippines | 1 | |
#23 | Poland | 1 | |
#24 | Serbia | 1 | |
#25 | Singapore | 1 | |
#26 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Foods and drinks | |
#4 | Medical technology | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Foods | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Diagnosis and surgery | |
#8 | Analysing materials | |
#9 | Special acyclic compounds | |
#10 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Rocher Jean-Philippe | 44 |
#2 | Palombi Giovanni | 32 |
#3 | Le Poul Emmanuel | 32 |
#4 | Bolea Christelle | 32 |
#5 | Poli Sonia Maria | 29 |
#6 | Trabanco-Suarez Andres Avelino | 29 |
#7 | Gagliardi Stefania | 28 |
#8 | Cid-Nunez Jose Maria | 27 |
#9 | Macdonald Gregor James | 25 |
#10 | Campo Brice | 20 |
Publication | Filing date | Title |
---|---|---|
GB201914623D0 | Novel compounds | |
GB201914624D0 | Novel compounds | |
GB201317022D0 | Polymorphs | |
WO2013107862A1 | NOVEL 2-AMINO-4,5,6,8-TETRAHYDROPYRAZOLO[3,4-b]THIAZOLO [4,5-d]AZEPINE DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS | |
GB201220560D0 | Novel compounds ll | |
GB201220558D0 | Novel compounds 1 | |
GB201219691D0 | New compounds ll | |
GB201219690D0 | New compounds l | |
GB201219689D0 | Novel Heteroaromatic derivatives I | |
GB201216657D0 | New organic compounds 1 | |
GB201210530D0 | Extended release formulations | |
GB201206731D0 | Novel compounds | |
GB201206730D0 | Novel compounds 1 | |
GB201204962D0 | Pharmaceutical combination products for parkinsons disease | |
GB201201736D0 | Novel heterocyclic compounds 4 | |
GB201201740D0 | Novel heterocyclic compounds 3 | |
GB201201747D0 | Novel heterocyclic compounds 1 | |
GB201201746D0 | Novel heterocyclic compounds 2 | |
GB201200800D0 | New organic compounds | |
GB201200245D0 | Novel organic compounds II |